A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019

References

• Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1–61. doi:10.1016/bs.acr.2020.10.001
   PubMed Web of Science ®Google Scholar
• Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013;47 Suppl:2–6. doi:10.1097/MCG.0b013e3182872f29
   PubMed Web of Science ®Google Scholar
• El-Kassas M, Cabezas J, Coz PI, Zheng MH, Arab JP, Awad A. Nonalcoholic Fatty Liver Disease: current Global Burden. Semin Liver Dis. 2022;42(3):401–412. doi:10.1055/a-1862-9088
   PubMedGoogle Scholar
• Salaheldin M, Aly H, Lau L, Afify S, El-Kassas M. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: the Next Threat after Viral Hepatitis. Diagn Basel Switz. 2023;13(16):2631. doi:10.3390/diagnostics13162631
   Web of Science ®Google Scholar
• Hamed MA, Ali SA. Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol. 2013;5(6):311–322. doi:10.4254/wjh.v5.i6.311
   PubMedGoogle Scholar
• Ezzat R, Eltabbakh M, El Kassas M. Unique situation of hepatocellular carcinoma in Egypt: a review of epidemiology and control measures. World J Gastrointest Oncol. 2021;13(12):1919–1938. doi:10.4251/wjgo.v13.i12.1919
   PubMed Web of Science ®Google Scholar
• Jean K, Tawheed A, Nguyen LBL, et al. Changes in Presentation, Treatment, and Survival of Patients with Hepatocellular Carcinoma in Damietta, Egypt, 2007–2019: a Retrospective Monocentric Cohort Study. J Hepatocell Carcinoma. 2023;10:99–111. doi:10.2147/JHC.S391511
   PubMed Web of Science ®Google Scholar
• El-Akel W, El-Sayed MH, El Kassas M, et al. National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care. J Viral Hepat. 2017;24(4):262–267. doi:10.1111/jvh.12668
   PubMed Web of Science ®Google Scholar
• Esmat G, Elbaz T, Elsharkawy A, Abdullah M, El Kassas M. Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt. Expert Rev Anti Infect Ther. 2020;18(7):637–642. doi:10.1080/14787210.2020.1758065
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet Lond Engl. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• National Cancer Registry Program of Egypt (NCRPE). Reports and Statistics - Damietta, 2012. Available from: http://cancerregistry.gov.eg/. Accessed May 28, 2024.
   Google Scholar
• Shaker MK, Abdella HM, Khalifa MO, El Dorry AK. Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases. Liver Int Off J Int Assoc Study. Liver. 2013;33(10):1601–1606. doi:10.1111/liv.12209
   Google Scholar
• Abd-Elsalam S, Elwan N, Soliman H, et al. Epidemiology of liver cancer in Nile delta over a decade: a single-center study. South Asian J Cancer. 2018;7(1):24–26. doi:10.4103/sajc.sajc_82_17
   PubMedGoogle Scholar
• Schütze M, Boeing H, Pischon T, et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ. 2011;342:d1584. doi:10.1136/bmj.d1584
   PubMedGoogle Scholar
• Welzel TM, Graubard BI, Quraishi S, et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108(8):1314–1321. doi:10.1038/ajg.2013.160
   PubMed Web of Science ®Google Scholar
• Matsushita H, Takaki A. Alcohol and hepatocellular carcinoma. BMJ Open Gastroenterol. 2019;6(1):e000260. doi:10.1136/bmjgast-2018-000260
   PubMed Web of Science ®Google Scholar
• Abou El Azm AR, Yousef M, Mansour N, Awad A, El Dardiry S, Abdel Aziz I. New Insights on Non-B non-C Hepatocellular Carcinoma in Mid Delta Region, Egypt. J Gastrointest Cancer. 2014;45(3):276–283. doi:10.1007/s12029-013-9573-8
   PubMedGoogle Scholar
• Cho EJ, Kwack MS, Jang ES, et al. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area. Digestion. 2011;84 Suppl 1:17–22. doi:10.1159/000333210
   PubMed Web of Science ®Google Scholar
• Noda Y, Kawaguchi T, Kuromatsu R, et al. Prognostic profile of patients with non-viral hepatocellular carcinoma: a comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis. Oncol Lett. 2019;18(1):227–236. doi:10.3892/ol.2019.10285
   PubMed Web of Science ®Google Scholar
• Hatanaka K, Kudo M, Fukunaga T, et al. Clinical characteristics of NonBNonC- HCC: comparison with HBV and HCV related HCC. Intervirology. 2007;50(1):24–31. doi:10.1159/000096309
   PubMed Web of Science ®Google Scholar
• Weinmann A, Alt Y, Koch S, et al. Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma. BMC Cancer. 2015;15:210. doi:10.1186/s12885-015-1197-x
   PubMed Web of Science ®Google Scholar
• Wu J, Liu W, Qiu X, et al. A Noninvasive Approach to Evaluate Tumor Immune Microenvironment and Predict Outcomes in Hepatocellular Carcinoma. Phenomics Cham Switz. 2023;3(6):549–564. doi:10.1007/s43657-023-00136-8
   PubMedGoogle Scholar
• Rawi S, Wu GY. Pathogenesis of Thrombocytopenia in Chronic HCV Infection: a Review. J Clin Transl Hepatol. 2020;8(2):184–191. doi:10.14218/JCTH.2020.00007
   PubMed Web of Science ®Google Scholar
• Toyoda H, Kariyama K, Hiraoka A, et al. Improved survival of viral hepatocellular carcinoma but not non-viral hepatocellular carcinoma from 2000 to 2020: a multi-centre cohort study of 6007 patients from high-volume academic centres in Japan. Aliment Pharmacol Ther. 2022;56(4):694–701. doi:10.1111/apt.17088
   PubMed Web of Science ®Google Scholar